Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood triglyceride amount,,RS:0004409,Jcl:WI,male,154 days,7,,CMO:0000360,serum triglyceride level,,,,312.39088,mg/dl,22.124,58.5346,MMO:0000328,solid phase colorimetry,,0.0,,,,,control condition,110225,control condition 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood triglyceride amount,,RS:0004409,Jcl:WI,male,154 days,7,,CMO:0000360,serum triglyceride level,,,,319.47056,mg/dl,34.5134,91.314,MMO:0000328,solid phase colorimetry,,0.0,,,,,vildagliptin (30 mg/kg/d) (for 106 days),110226,vildagliptin (30 mg/kg/d) (for 106 days) 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood cholesterol amount,,RS:0004409,Jcl:WI,male,154 days,7,,CMO:0000363,serum total cholesterol level,,,,30.888,mg/dl,1.9305,5.1076,MMO:0000328,solid phase colorimetry,,0.0,,,,,control condition,110229,control condition 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood cholesterol amount,,RS:0004409,Jcl:WI,male,154 days,7,,CMO:0000363,serum total cholesterol level,,,,29.7297,mg/dl,1.5444,4.0861,MMO:0000328,solid phase colorimetry,,0.0,,,,,vildagliptin (30 mg/kg/d) (for 106 days),110230,vildagliptin (30 mg/kg/d) (for 106 days)